LHLucy Hargreaves

Lucy Hargreaves

*This is an algorithmically generated author record based on publicly available information.

Lucy Hargreaves has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical Characteristics and Patient Burden of Cluster Headache in Brazil: A Real-World Study

    by Taleen Karnieg, Maurice Vincent, James Martinez, William Whitton, Lucy Hargreaves, Emmanuel Papadimitropoulos

    Introduction Cluster headache (CH) is a debilitating condition with health-related and economic burden to patients, including reduced quality of life (QoL) and suicidality. Brazilian data on comorbidities, symptoms, or impact on QoL and productivity remain limited. This study aims to assess CH’s impact on patients' QoL, overall health, and employment in Brazil from physicians’ and patients’ perspectives. Methods Data were extracted from the Adelphi Real World CH Disease Specific Programme™, a real-world, cross-sectional survey of physicians and their patients with CH in Brazil from November 2021–July 2022. Physicians reported on demographics, clinical characteristics, comorbidities, and suicidality. Patients reported CH’s impact on feelings/reactions, suicidality, employment using the Work Productivity and Activity Impairment questionnaire, and QoL using the EuroQol 5 Dimension 5 Level survey. Data analyses were conducted with R Statistical software (v4.1.2). Results Patients completed 177 forms, while physicians completed 450 forms. Patients had episodic CH (ECH, n = 355) and chronic CH (CCH, n = 95). Common comorbidities were anxiety, insomnia, hypertension, depression, and dyslipidemia. Stress and lack of sleep were key physician-reported CH triggers, and 10.34% of patients had considered suicide. The presence of CH may have led to absenteeism (11.45%) and presenteeism (30.08% overall work impairment, 29.38% activity impairment, and 29.36% impairment while working). Conclusions CH carries a significant disease burden and negative socioeconomic impact, especially among patients with CCH. Stress was the most common trigger for both attacks and bouts with notable rates of suicidality. This indicates a need among physicians and patients for targeted and more efficacious interventions to reduce CH’s burden, improving patients' QoL.


  • Open Access

    Differences in Patient-Physician Satisfaction for Migraine Treatment Medications in Patients with and without Medication-Overuse Headache: A Cross-Sectional Real-World Survey

    by Ryotaro Ishii, Takahiro Kitano, Masahiro Iijima, Mitsuhiro Nagano, Reiko Yoshikawa, James Jackson, Sophie Barlow, Emily Green, William Whitton, Lucy Hargreaves, et al.

    Introduction Medication overuse headache (MOH) is incurred by the excessive use of acute medications, including over-the-counter (OTC) treatments. This study aimed to characterize the burden, management, and treatment satisfaction of patients with migraine with or without MOH in Japan. Methods Data were derived from the Adelphi Migraine Disease Specific Programme (DSP)™, a cross-sectional survey conducted in Japan from August 2023 to February 2024. Physicians provided data for consecutive patients, including demographics, clinical characteristics, current treatment, OTC treatment usage, and treatment satisfaction. Patients voluntarily reported their symptom burden, migraine pain severity, and treatment satisfaction. Alignment between physician and patient regarding treatment satisfaction was assessed using Cohen’s weighted kappa statistics and multivariable regression models. Results Overall, 122 physicians provided data for 820 patients with migraine, 7.0% (n = 57) of whom had a diagnosis of MOH; 41.5% (n = 340) of patients self-reported data, with 3.2% (n = 11) having a diagnosis of MOH. Patients with MOH were more likely to experience chronic migraine (79%, n = 45), greater migraine frequency, and more severe migraine than those without MOH. Ninety percent of both groups received acute treatment. Patients with MOH were significantly more likely to receive preventive treatment than those without MOH (86% vs 56.6%, p < 0.001). OTC medication use was reported at 3.3% by physicians and 11.2% by patients. The alignment between physician and patient treatment satisfaction was low for acute treatment. The exploratory model analysis indicated that OTC use may have contributed to this misalignment. Conclusion Our study revealed that the alignment regarding treatment satisfaction with acute medications is low. OTC treatment usage may have inflated physician satisfaction with prescribed acute medications and caused a discrepancy regarding satisfaction of patients with MOH. To improve patient outcomes, it is essential to align drug effectiveness ratings between physicians and patients by enhancing communication and mutual understanding.

  • Open Access

    Underdiagnosis and impact of menstrual migraine in real‐world clinical practice: A real‐world survey

    by Gisela Terwindt, Jessica Ailani, Jessica Cirillo, Lucy Abraham, Aaron Jenkins, Phillip Saccone, Karin Hygge Blakeman, Feng Dai, James Jackson, Sophie Barlow, et al.

    Objective: This cross‐sectional study aimed to evaluate the frequency of menstrual migraine (MM) reporting in clinical practice and to compare the clinical burden, treatment patterns, and patient satisfaction between those with and without MM.Background: People with MM experience more severe, disabling, and prolonged attacks than people with non‐MM. Research indicates that approximately two thirds of females with migraine may experience MM; however, the prevalence of MM is often underreported and there is a lack of awareness regarding the condition.Methods: This study analyzed secondary data from the Adelphi Real World Migraine Disease Specific Programme™, a cross‐sectional survey with retrospective data collection conducted across France, Germany, Italy, Spain, the United Kingdom, and the United States from May 2022 to February 2024. Physicians completed an attitudinal survey, and provided data for consecutively consulting patients with migraine, containing questions on demographics, clinical characteristics, treatment history (including reasons for treatment choice, treatment satisfaction, and adherence), and symptomatic burden. Patients voluntarily completed a questionnaire on their current symptom burden, migraine pain severity, treatment satisfaction, and other patient‐reported outcomes. Outcomes between patients with and without a physician‐confirmed diagnosis of MM were compared using statistical and comparative tests. Patients were eligible for inclusion if they were female, aged 18–55 years, and had menstrual periods.Results: Overall, 627 physicians reported data on 3215 patients who met the inclusion criteria, with 1037 (32.3%) having a physician‐confirmed diagnosis of MM. The patient questionnaire was completed by 931 patients, of whom 340 (36.5%) had a physician‐confirmed diagnosis of MM. While physicians estimated on average that 38.5% of their patients experienced MM, 32.3% of patients had a physician‐confirmed diagnosis of MM, as reported from the individual patient record forms. Additionally, 14.0% of patients without a physician‐confirmed diagnosis of MM self‐reported menstruation as a trigger for their migraine. Clinically, there were few differences observed between patient groups, except for higher migraine attack severity in patients with MM (p < 0.001). Patients with and without MM were prescribed a similar number of acute treatments (mean [standard deviation, SD]: both 1.1 [0.7]), but patients with physician‐confirmed MM were prescribed fewer preventive treatments (mean [SD]: 0.5 [0.6] vs. 0.6 [0.6], p < 0.001). Lower physician‐reported satisfaction with acute (21.6% vs. 29.4%, p = 0.024) and preventative treatment (22.0% vs. 34.8%, p = 0.010) was observed in patients with MM compared to those without MM. Patients with MM also reported less satisfaction with their acute treatment than those without MM (19.4% vs. 27.8%, p = 0.013).Conclusions: This study highlights differences between patients with and without MM. Patients with MM experienced more severe attacks and reported lower treatment satisfaction, according to both patients and their physicians, compared to those without MM. Further real‐world insights on patient experience, including migraine attack severity, are necessary to alleviate the burden of MM.